- Technology and Data
- Front End Sales and Marketing
- Allergy
- HIV
- Women's Health
- Migraine
- Compounding
- Continuous Glucose Monitoring
- Mental Health Awareness
- Veterinary Pharmacy
- CBD
- Infectious Disease
- Eye Health
- Digestive Health
- Biosimilars
- Influenza
- Shingles
- COPD Management
- Pediatrics
- Generics
- Pain Management
- COVID-19
- Immunization
- Oncology
- Anticoagulants
- Autoimmune Diseases
- Dermatology
- Diabetes
- Respiratory
- Heart Health
- Cardiovascular Clinical Consult
ALF issues warning on dangers of excess acetaminophen
The American Liver Foundation (ALF) has issued a warning based on a recent study dealing with the effects of high doses of acetaminophen on the liver. The study, published recently in the Journal of the American Medical Association, showed that healthy adults who took the maximum recommended dose of acetaminophen for two weeks had drastically increased liver enzyme levels, which could lead to liver damage.
ALF issues warning on dangers of excess acetaminophen
The American Liver Foundation (ALF) has issued a warning based on a recent study dealing with the effects of high doses of acetaminophen on the liver. The study, published recently in the Journal of the American Medical Association, showed that healthy adults who took the maximum recommended dose of acetaminophen for two weeks had drastically increased liver enzyme levels, which could lead to liver damage. ALF recommended that people not exceed 3 gm of acetaminophen a day for any prolonged period of time.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
Antiseizure Medications Linked to Serious Potential Reaction, FDA Warns
November 30th 2023Levetiracetam and clobazam can cause Drug Reaction with Eosinophilia and Systemic Symptoms, which can start as a rash but progress quickly, potentially resulting in injury to internal organs, hospitalization, and death.
Examining Barriers to Care in Diabetic Retinopathy Screening
November 30th 2023Prior research has shown the association between various socioeconomic variables and lower adherence to diabetic retinopathy screening, but few have elaborated on the patient perspective to understand the reason behind this association.
